BIOTECH (118) John Crowley’s Love for Pompe Disease Drug Development from Novazyme Pharmaceuticals to Amicus Therapeutics March 8, 2024March 8, 2024
BIOTECH (117) Amylyx Pharmaceuticals: ALS Drug Combo of Sodium Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA) March 8, 2024March 8, 2024
BIOTECH (114) UCB Ra Pharmaceuticals: mRNA Display Platform for Macrocyclic Peptides March 7, 2024March 7, 2024